SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-22-028518
Filing Date
2022-02-04
Accepted
2022-02-04 17:22:01
Documents
2
Group Members
JOSHUA RICHARDSONJULIET TAMMENOMS BAKKERLONGITUDE PRIME FUND, L.P.LONGITUDE PRIME PARTNERS , LLCLONGITUDE VENTURE PARTNERS III, L.P.PATRICK G. ENRIGHT

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d241934dsc13da.htm SC 13D/A 135505
2 EX-99.1 d241934dex991.htm EX-99.1 10690
  Complete submission text file 0001193125-22-028518.txt   148045
Mailing Address 1820 GATEWAY DRIVE SUITE 110 SAN MATEO CA 94404
Business Address 1820 GATEWAY DRIVE SUITE 110 SAN MATEO CA 94404 (605) 376-8679
Sierra Oncology, Inc. (Subject) CIK: 0001290149 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-89009 | Film No.: 22594631
SIC: 2834 Pharmaceutical Preparations

Mailing Address 800 EL CAMINO, SUITE 220 MENLO PARK CA 94025
Business Address 800 EL CAMINO, SUITE 220 MENLO PARK CA 94025 650-845-5700
Longitude Capital Partners III, LLC (Filed by) CIK: 0001713663 (see all company filings)

IRS No.: 811668051 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A